Literature DB >> 9143816

Silicone punctal plug migration resulting in dacryocystitis and canaliculitis.

S Rumelt1, H Remulla, P A Rubin.   

Abstract

PURPOSE: One of the modalities of treating dry eyes is punctal plugs. They are usually used for temporary occlusion of the lacrimal drainage system. Among the complications associated with silicone punctal plugs are extrusion, downward migration, irritation, and epiphora. To our knowledge, this is the first report of dacryocystitis and canaliculitis as a result of spontaneous migration of punctal plugs into the lacrimal drainage system.
METHODS: We describe the sequelae of spontaneous migration of silicone punctal plugs into the lacrimal drainage system in two patients with dry eyes.
RESULTS: In two patients, spontaneous migration of silicone punctal plugs into the canaliculus or the lacrimal sac, respectively, resulted in canaliculitis or dacryocystitis.
CONCLUSION: Smaller sized newer generation punctal plugs were designed to facilitate insertion; however, this design also increases the likelihood of proximal migration within the lacrimal drainage system. The importance of monitoring patients after punctal-plug placement cannot be over-emphasized.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143816     DOI: 10.1097/00003226-199705000-00022

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  12 in total

1.  Surgical management of severe canaliculitis due to intracanalicular plug migration using fish-hook-type retractors: a report of two patients.

Authors:  Yumiko Ban; Shinji Ideta; Murat Dogru; Yoko Ogawa; Eiki Goto; Jun Shimazaki
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

Review 2.  Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.

Authors:  Olivia L Lanier; Miranda G Manfre; Claire Bailey; Zhen Liu; Zachary Sparks; Sandesh Kulkarni; Anuj Chauhan
Journal:  AAPS PharmSciTech       Date:  2021-03-14       Impact factor: 3.246

3.  Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.

Authors:  K Kamiya; M Nakanishi; R Ishii; H Kobashi; A Igarashi; N Sato; K Shimizu
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

4.  A new strategy to sustained release of ocular drugs by one-step drug-loaded microcapsule manufacturing in hydrogel punctal plugs.

Authors:  Jiajun Xie; Changjun Wang; Qingyao Ning; Qi Gao; Changyou Gao; Zhongru Gou; Juan Ye
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-08       Impact factor: 3.117

5.  Bilateral canaliculitis following SmartPLUG insertion for dry eye syndrome post LASIK surgery.

Authors:  Marius Scheepers; Andrew Pearson; Michel Michaelides
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

6.  Clinical evaluation of the therapeutic effects of atelocollagen absorbable punctal plugs.

Authors:  Kaori Hirai; Yoji Takano; Eiichi Uchio; Kazuaki Kadonosono
Journal:  Clin Ophthalmol       Date:  2012-01-16

7.  Punctal eversion with silicone plug resulting in ocular surface trauma.

Authors:  Brad P Barnett; Esen K Akpek; Albert S Jun
Journal:  BMJ Case Rep       Date:  2020-05-27

Review 8.  Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease.

Authors:  Naz Jehangir; Greg Bever; S M Jafar Mahmood; Majid Moshirfar
Journal:  J Ophthalmol       Date:  2016-03-07       Impact factor: 1.909

9.  Intracanalicular antibiotics may obviate the need for surgical management of chronic suppurative canaliculitis.

Authors:  E Ravindra Mohan; Sachin Kabra; Priti Udhay; H N Madhavan
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

10.  A treatment method for chronic suppurative lacrimal canaliculitis using chalazion forceps.

Authors:  Xiuming Jin; Fangli Fan; Fan Zhang; Yingying Zhao; Renjian Hu
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.